Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer (Q45760116)

15 December 2017

title

Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer (English)

1 reference

15 December 2017

adaptive radiation therapy

main subject

0 references

author

Anna Margherita Maffione

4

1 reference

15 December 2017

Domenico Rubello

9

Domenico Rubello

1 reference

15 December 2017

Maria Cristina Marzola

2

Maria Cristina Marzola

1 reference

15 December 2017

Gaia Grassetto

6

Gaia Grassetto

1 reference

15 December 2017

Lucia Rampin

5

Lucia Rampin

1 reference

15 December 2017

Sotirios Chondrogiannis

1

Sotirios Chondrogiannis

1 reference

15 December 2017

author name string

Alice Ferretti

3

1 reference

15 December 2017

Cristina Nanni

7

1 reference

15 December 2017

Patrick M Colletti

8

1 reference

15 December 2017

publication date

14 May 2013

1 reference

15 December 2017

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

15 December 2017

volume

40

1 reference

15 December 2017

issue

9

1 reference

15 December 2017

page(s)

1356-1364

1 reference

15 December 2017

The natural history of prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

What is the role of digital rectal examination in men undergoing serial screening of serum PSA levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine (FCH) as a PET Tumor Imaging Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2433-8

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

21 January 2018

1 reference

12 December 2020

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy

1 reference

12 December 2020

A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy

1 reference

12 December 2020

Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation

1 reference

12 December 2020

Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?

1 reference

12 December 2020

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy

1 reference

12 December 2020

10.1007/S00259-013-2433-8

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

1033101626

0 references

1 reference

15 December 2017